300463: Maccura Biotechnology Co.Ltd - Summary | Jitta

Maccura Biotechnology Co.Ltd

CHN:300463

Price
CN¥18.32
Loss Chance
41.7%
6.60JITTA SCORE
60.19%Under Jitta Line
Jitta Ranking
201 / 456
1,836 / 4,821
Grow your money with Jitta Ranking. See details.
HISTORICAL JITTA SCORE
Jitta Factors
Growth Opportunity (46)
Recent Business Performance (22)
Financial Strength (89)
Return to Shareholders (81)
Competitive Advantage (61)
Jitta Signs
Revenue and EarningConsistent High Growth in the past 5 years
Operating MarginConsistent
Debt LevelLow Long Term Debt
Dividend PayoutIncreasing Every Year
Interest Coverage RatioVery Good
SG&A to SalesDecreasing
Recent Business PerformanceEarning decline 21.83% in the last quarter (yoy)
Cash Conversion CycleMore than 120 days
Key Stats
Jitta Score
Jitta Line
6.60
60.19%
4.77
747.44%
Life Sciences Tools and Services
7.95
136.93%
6.86
68.67%
5.21
665.09%
COMPANY DESCRIPTION
Maccura Biotechnology Co.Ltd engages in the research, development, manufacture, and sale of IVD products and related services in China and internationally. The company offers immunoassay products, such as chemiluminescence analyzers and reagents; clinical chemistry reagents for hepatic function, glycometabolism, iron and other, renal function, coagulation, special protein, cardiac, and lipids; and clinical laboratory products, such as automatic hematology, and automatic and semi-automatic coagulation analyzers. It also provides SARS-COV-2(COVID-19) products that includes nucleic acid detection kit and other products; glucometers; POCT products, such as fluorescence immunoassay analyzers, as well as colloidal gold kits; molecular diagnosis products, such as PCR kit; and pathology products. The company was incorporated in 1994 and is based in Chengdu, China.